Elsevier

Annals of Oncology

Volume 32, Issue 3, March 2021, Pages 309-322
Annals of Oncology

Special Article
Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

https://doi.org/10.1016/j.annonc.2020.11.014Get rights and content
Under an Elsevier user license
open archive

Highlights

  • This EHA-ESMO Clinical Practice Guideline provides key recommendations on the management of multiple myeloma.

  • Authorship includes a multidisciplinary group of experts from different institutions and countries in Europe.

  • Key treatment recommendations are provided for both newly diagnosed myeloma patients and patients with relapsed/refractory disease.

  • Recommendations for the treatment of plasma cell leukaemia, solitary plasmacytoma and smouldering myeloma are also provided.

  • Key recommendations for myeloma complications, including bone disease and renal impairment, are included.

Key words

multiple myeloma
clinical practice guidelines
diagnosis
treatment
follow-up
prognosis

Cited by (0)

These Guidelines were developed by the European Hematology Association (EHA) and European Society for Medical Oncology (ESMO). The two societies nominated authors to write the guidelines as well as reviewers to comment on them. These guidelines were approved by the EHA Board and the ESMO Guidelines Committee in November 2020.